All In Biotech

Free tool

FAERS Monitor: Azactam

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 050580 or its brand name (Azactam, Aztreonam). Reports on generic versions are filed under their own applications.

Reports

2,727

Serious

2,510

92% of reports

Hospitalization

1,413

Death reported

590

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • off label use194
  • pyrexia176
  • eosinophilia160
  • drug ineffective152
  • dyspnoea134
  • rash131
  • acute kidney injury127
  • drug reaction with eosinophilia and systemic symptoms120
  • thrombocytopenia117
  • septic shock103
  • condition aggravated101
  • renal failure98
  • drug hypersensitivity94
  • pneumonia91
  • death88

Reports by year received

View as table
YearReports
200442
200546
200651
200737
200847
200950
201050
201185
201278
201375
2014124
2015104
2016148
2017139
2018158
2019206
2020207
2021264
2022161
2023183
2024215
2025149
2026108

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,051,432 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
eosinophiliaSignal16071.161.110,892
drug reaction with eosinophilia and systemic symptomsSignal12036.130.34,050
septic shockSignal10318.315.11,667
thrombocytopeniaSignal1178.16.8722
acute kidney injurySignal1276.45.4578
renal failureSignal985.74.7377
pyrexiaSignal1763.93.4387
drug hypersensitivitySignal943.73.1188
condition aggravatedSignal1012.62.196
rashSignal1312.32.099
pneumoniaSignal912.21.857
dyspnoea1341.81.551
off label use1941.71.559
drug ineffective1520.90.82
death880.80.65

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.